Trials / Completed
CompletedNCT00124293
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury
A Multi Centre Observational Study to Evaluate the Incidence and Magnitude of Haemorrhagic Progression of Cerebral Contusions and the Identification of Important Safety Issues Following Traumatic Brain Injury
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted in North America. The purpose of this study is to evaluate the occurrence and severity of bleeding in brain injury and to identify important safety issues following traumatic brain injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | activated recombinant human factor VII |
Timeline
- Start date
- 2004-10-06
- Primary completion
- 2005-11-23
- Completion
- 2005-11-23
- First posted
- 2005-07-27
- Last updated
- 2017-02-27
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00124293. Inclusion in this directory is not an endorsement.